The Spanish regulator has granted approval to the German division of Venus Remedies to sell Meropenem in Spain, leading to a 5% increase in the upper circuit lock on shares.

Venus Remedies is a pharmaceutical company that focuses on creating and producing affordable and inventive drugs through research. They have a notable presence in India and are expanding worldwide. The German branch of the company was granted permission by the Spanish regulatory body to sell Meropenem in Spain, leading to a…

A lire également

Lire également